Agenus Inc SEC filings AGEN
Agenus Inc has 1,003 filings in SEC EDGAR's recent list, going back to Apr 29, 2014. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | May 13, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Apr 30, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Apr 20, 2026 |
| DEF 14A | Proxy statement | Apr 30, 2025 | Apr 30, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Apr 18, 2025 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 11, 2024 |
| DEFA14A | Additional proxy material | Feb 29, 2024 | — |
| DEF 14A | Proxy statement | Feb 26, 2024 | Apr 3, 2024 |
| PRE 14A | Preliminary proxy statement | Feb 15, 2024 | Apr 3, 2024 |
| DEF 14A | Proxy statement | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Jun 22, 2022 | Aug 4, 2022 |
| PRE 14A | Preliminary proxy statement | Jun 9, 2022 | Aug 4, 2022 |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 8, 2022 |
| DEFA14A | Additional proxy material | May 10, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 15, 2021 |
| DEF 14A | Proxy statement | Apr 28, 2020 | Jun 16, 2020 |
| DEF 14A | Proxy statement | Apr 26, 2019 | Jun 19, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2019 | Jun 19, 2019 |
| DEF 14A | Proxy statement | Apr 26, 2018 | Jun 20, 2018 |
| DEF 14A | Proxy statement | May 8, 2017 | Jun 28, 2017 |
| DEFA14A | Additional proxy material | May 19, 2016 | — |
| DEF 14A | Proxy statement | Apr 28, 2016 | Jun 14, 2016 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2016 | Jun 14, 2016 |
| DEFA14A | Additional proxy material | Apr 30, 2015 | — |
| DEF 14A | Proxy statement | Apr 30, 2015 | Jun 24, 2015 |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AGEN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lexington, MA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1098972
- Former names
- ANTIGENICS INC /DE/ (until Jan 5, 2011)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.